Top 10 Companies in Europe in 2021 by No. of Marketed Products

Medtronic Plc, Siemens Healthineers AG, Smith & Nephew Plc, Vygon SA, and Rudolf Medical GmbH Co KG are the top 5 Companies in Europe in 2021 by number of marketed products. Cumulatively, the top 10 companies in Europe reported number of marketed products of 3,662, the highest marketed products were reported by Medtronic Plc (1,143), followed by Siemens Healthineers AG (501) and Smith & Nephew Plc (376), while Koninklijke Philips NV (155) stood the lowest. In terms of the geographical split, 7 out of 10 companies are based in Europe, while 3 are based in Asia. They employed a total of 277,864 people in 2021. Ireland-based Medtronic Plc is the leading company in Europe in 2021 by number of marketed products (FY 2021). It is a medical technology company that designs, develops, manufactures, and markets a wide range of medical devices and solutions. It offers products for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous renal and neurological diseases, spine and musculoskeletal disorders, and diseases of the ear, nose, and throat. The company reported 1,143 marketed products and generated revenue of $30,117 million, with average revenue growth of 4.16% primarily due to the recovery of global procedural sales resulting from the pandemic and increased sales of Cardiac Rhythm Management and Cardiac Ablation Solutions products. The company operates through four reportable segments: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit, and operates through 350 locations in over 150 countries and employs 95,000 people. Germany -based Siemens Healthineers AG is one of the leading companies in Europe in 2021 by number of marketed products (FY 2021). It is a subsidiary of Siemens AG, a medical technology company that designs, develops, produces, and distributes diagnostic imaging systems, clinical and workflow systems and solutions, and systems for minimally invasive procedures. The company reported 501 marketed products and generated revenue of $20,516 million, with average revenue growth of 24.5% due to robust sales in EMEA, Asia, Australia, and the Americas. The company reports its operations under four segments: Diagnostics, Imaging, Varian, and Advanced Therapies in over 180 countries and employs 68,700 people.